# Naïve HIV POC Monotherapy Trial

> **NCT00617526** · PHASE2 · COMPLETED · sponsor: **Ardea Biosciences, Inc.** · enrollment: 48 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** RDEA806 400 mg
- **DRUG:** Placebo
- **DRUG:** RDEA806 1000 mg
- **DRUG:** RDEA806 600 mg
- **DRUG:** RDEA806 800 mg

## Key facts

- **NCT ID:** NCT00617526
- **Lead sponsor:** Ardea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617526, "Naïve HIV POC Monotherapy Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00617526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*